Stay updated on Efgartigimod SC in Bullous Pemphigoid: Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.

Latest updates to the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page
- Check4 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating the record is currently inaccessible and users cannot view the study information or related data.SummaryDifference18%

- Check11 days agoChange DetectedRevision tag changed from v3.6.6 to v3.7.0, indicating the page is rendered with a newer template/version. This update affects the underlying rendering rather than the study content or visible details.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page version tag was updated from Revision: v3.6.5 to Revision: v3.6.6. This indicates a backend/template update without changes to the study content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a small update to the page's history.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision label changed from v3.6.3 to v3.6.4, signaling a minor patch to the study page rather than an update to study data.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision tag updated to v3.6.3, replacing v3.6.2; this indicates a minor platform update without changes to the page's content.SummaryDifference0.0%

Stay in the know with updates to Efgartigimod SC in Bullous Pemphigoid: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.